Hemenway Trust Co LLC Reduces Stock Holdings in Roche Holding AG (OTCMKTS:RHHBY)

Hemenway Trust Co LLC reduced its stake in shares of Roche Holding AG (OTCMKTS:RHHBY) by 61.0% during the second quarter, Holdings Channel reports. The firm owned 7,006 shares of the company’s stock after selling 10,975 shares during the quarter. Hemenway Trust Co LLC’s holdings in Roche were worth $243,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the stock. Archer Investment Corp boosted its position in shares of Roche by 10.6% during the second quarter. Archer Investment Corp now owns 6,810 shares of the company’s stock valued at $236,000 after purchasing an additional 652 shares in the last quarter. Rhumbline Advisers boosted its holdings in shares of Roche by 0.9% during the 2nd quarter. Rhumbline Advisers now owns 103,985 shares of the company’s stock valued at $3,605,000 after buying an additional 904 shares in the last quarter. Waldron Private Wealth LLC purchased a new stake in shares of Roche in the 2nd quarter worth about $263,000. Hantz Financial Services Inc. bought a new position in shares of Roche in the 2nd quarter worth about $1,164,000. Finally, Lee Danner & Bass Inc. purchased a new position in Roche during the 2nd quarter valued at about $327,000.

Analysts Set New Price Targets

A number of brokerages have weighed in on RHHBY. Deutsche Bank Aktiengesellschaft upgraded shares of Roche from a “sell” rating to a “hold” rating in a report on Friday, May 17th. The Goldman Sachs Group initiated coverage on Roche in a research note on Thursday, May 30th. They issued a “sell” rating on the stock. Two analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $40.00.

Roche Price Performance

OTCMKTS:RHHBY traded down $0.31 on Friday, reaching $40.64. 1,738,099 shares of the stock traded hands, compared to its average volume of 2,305,609. The company has a quick ratio of 1.04, a current ratio of 1.35 and a debt-to-equity ratio of 0.75. Roche Holding AG has a 12 month low of $29.20 and a 12 month high of $42.43. The company’s fifty day simple moving average is $39.02 and its 200 day simple moving average is $34.55.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.